InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Lawley Lori D, Chief Financial Officer. Officer active across 2 companies, notably LUMOS PHARMA, INC.. Aggregated, 5 filings have been published. The latest transaction was disclosed on 1 April 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
€2,284274 shares@ €8.336120.4% of flow
Common Stock
SEC:0001126234-22-000033:0·
€8,9231,000 shares@ €8.9228100.0% of flow
Common Stock
SEC:0001126234-22-000009·
€8,9231,000 shares@ €8.922879.6% of flow
Common Stock
SEC:0001126234-22-000009:0·
03,750 shares0
Common Stock
SEC:0001126234-21-000101·
03,750 shares0
Common Stock
SEC:0001126234-21-000101:0·
5 of 5 declarations
About Lawley Lori D
Lawley Lori D serves as Chief Financial Officer at Lumos Pharma, Inc. She is responsible for the company's financial management, including financial planning, risk management, and regulatory compliance. Her financial expertise is crucial for supporting the company's growth and sustainability.
